BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
Go back to BIOGEN publishes study results for high-dose nusinersen in Nature Medicine| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 205.70 -2.76 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $208.46 | 52 Week High | $333.65 | |||
| Open | $211.86 | 52 Week Low | $223.02 | |||
| Day High | $212.00 | P/E | 26.34 | |||
| Day Low | $205.65 | EPS | $7.81 | |||
| Volume | 1,156,882 | |||||
| (NASDAQ: IONS) | Delayed: 86.33 +3.15 (3.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.18 | 52 Week High | $62.68 | |||
| Open | $84.42 | 52 Week Low | $19.59 | |||
| Day High | $86.67 | P/E | N/A | |||
| Day Low | $82.95 | EPS | $0.00 | |||
| Volume | 2,646,708 | |||||
